Incyte
INCY
#1147
Rank
A$29.16 B
Marketcap
A$148.55
Share price
3.39%
Change (1 day)
35.51%
Change (1 year)

Incyte (INCY) Fails to deliver data

Key failure to deliver metrics for Incyte:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Incyte (INCY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Incyte (INCY) - since 2013

Volume in USD (price x number of shares), data since 2013

Incyte (INCY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$23.47 M-88.16%
2024A$0.19 B671.36%
2023A$25.71 M15.22%
2022A$22.31 M-30.83%
2021A$32.26 M-42.59%
2020A$56.2 M156.83%
2019A$21.88 M-55.79%
2018A$49.49 M223.95%
2017A$15.27 M-77.94%
2016A$69.25 M11.56%
2015A$62.07 M-15.95%
2014A$73.85 M760.63%
2013A$8.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
A$21.81 MA$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$2.36 MA$8.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$0.29 BA$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$29.26 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A$0.23 MA$9.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$1.75 MA$5.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$19.76 MA$75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
N/AA$0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
N/AA$40.39 M๐Ÿ‡บ๐Ÿ‡ธ USA